Inventiva S.A. American Depository Shares IVA
Analyst Ratings
- Consensus
- Buy — 9 Buy · 0 Hold · 0 Sell (9 analysts)
- Avg. Price Target
- $15.38 (+222.3% upside)
Key Stats
- Today's Range
- $4.53 – $4.81
- 50-Day Range
- $3.35 – $4.98
- 52-Week Range
- $2.94 – $7.98
- Volume
- 841K shs
- Average Volume
- 714K shs
- Market Cap
- $1.11 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.01%
- Days to Cover
- 1.00
About Inventiva S.A. American Depository Shares
Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.
Related Stocks
Compare head-to-head: IVA vs NVDA·IVA vs AAPL·IVA vs GOOGL·IVA vs GOOG
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.